PYNKF (PYNKF) Stock Price & Analysis
PYNKF (PYNKF) fell 2.55% to USD 0.21 as of June 10, 2026 at 03:50 UTC, according to Nexqual real-time market data.
PYNKF last closed at USD 0.22; the session ranged USD 0.21–0.22 on volume of 25,500 shares. Market capitalization is $31.64M, with a 52-week range of USD 0.11–0.53 (OQX). Source: Nexqual, June 10, 2026 at 03:50 UTC.
Key Statistics (as of June 10, 2026 at 03:50 UTC)
| Price | USD 0.21 |
|---|---|
| Change | ▼ 2.55% (down) |
| Previous Close | USD 0.22 |
| Open | USD 0.22 |
| Day Range | USD 0.21 – 0.22 |
| 52-Week Range | USD 0.11 – 0.53 |
| Volume | 25,500 shares |
| Market Cap | $31.64M |
| Exchange | OQX |
Technical Analysis (PYNKF)
Nexqual's technical model rates PYNKF "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:50 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.36 (neutral) |
| vs SMA50 | Below (USD 0.25) |
| MACD | -0.01 (negative) |
Analyst Ratings (PYNKF)
Wall Street analysts rate PYNKF "None", per Nexqual as of June 10, 2026 at 03:50 UTC.
| Consensus Rating | None |
|---|
Earnings (PYNKF)
| Next Earnings Date | 2026-08-25 |
|---|---|
| Revenue Estimate | $885,000 |
Source: Nexqual, June 10, 2026 at 03:50 UTC.
Financials & Fundamentals (PYNKF)
| Total Revenue | $2.14M |
|---|---|
| Revenue Growth (YoY) | -30.10% |
| Gross Margin | +83.74% |
| Operating Margin | -774.92% |
| Profit Margin | +0.00% |
| ROE | -284.87% |
| Debt / Equity | 6.38 |
| Current Ratio | 0.55 |
| Total Cash | $421,496 |
| Total Debt | $104,015 |
| Free Cash Flow | $-3.92M |
Source: Nexqual, June 10, 2026 at 03:50 UTC.
Financial Health Score (PYNKF)
Nexqual rates PYNKF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:50 UTC.
| Growth | Strong — Revenue +166% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $421K cash, no debt |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -285%, ROA -108.9% |
Ownership (PYNKF)
| Insider Ownership | +18.94% |
|---|---|
| Institutional Ownership | +19.20% |
| Shares Outstanding | 150.65M |
| Float | 82.24M |
Source: Nexqual, June 10, 2026 at 03:50 UTC.
Leadership (PYNKF)
PYNKF is led by Adrian Mendes, CEO & Director, per Nexqual as of June 10, 2026 at 03:50 UTC.
| CEO & Director | Adrian Mendes |
|---|---|
| Chief Financial Officer | Sara Brien |
| Vice President of Sales | Abbey Goodman (age 42) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ASAPF | Aurora Spine Corp | USD 0.16 | ▲ 6.04% |
| ADCOF | Adcore Inc. | USD 0.13 | ▼ 1.57% |
| BRSF | BRAIN SCIENTIFIC INC | USD 0 | ▲ 0% |
| AVCNF | Avicanna Inc. | USD 0.08 | ▼ 3.61% |
| EGTYF | Eguana Technologies Inc | USD 0.06 | ▼ 17.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:50 UTC. This page is informational and not investment advice.